Hawaii 2024 Regular Session

Hawaii House Bill HB1739 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	HOUSE OF REPRESENTATIVES H.B. NO. 1739 THIRTY-SECOND LEGISLATURE, 2024 STATE OF HAWAII A BILL FOR AN ACT relating to product labeling. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
2	2
3	3	HOUSE OF REPRESENTATIVES H.B. NO. 1739
4	4	THIRTY-SECOND LEGISLATURE, 2024
5	5	STATE OF HAWAII
6	6
7	7	HOUSE OF REPRESENTATIVES
8	8
9	9	H.B. NO.
10	10
11	11	1739
12	12
13	13	THIRTY-SECOND LEGISLATURE, 2024
14	14
15	15
16	16
17	17	STATE OF HAWAII
18	18
19	19
20	20
21	21
22	22
23	23
24	24
25	25
26	26
27	27
28	28
29	29
30	30
31	31	A BILL FOR AN ACT
32	32
33	33
34	34
35	35
36	36
37	37	relating to product labeling.
38	38
39	39
40	40
41	41
42	42
43	43	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
44	44
45	45
46	46
47	47	SECTION 1. Chapter 486, Hawaii Revised Statutes, is amended by adding a new section to part V to be appropriately designated and to read as follows: "§486- Human cells; product labeling; requirements; penalties. (a) No person doing business in the State shall knowingly or intentionally expose any other person to a product developed or tested using human cells unless the product bears a warning label containing: (1) A disclaimer that states that the product was developed or tested using one or more human cells; and (2) The address of a website disclosing: (A) The origin of each human cell that was used to develop or test the product was obtained; (B) The method by which each human cell that was used to develop or test the product was obtained; and (C) The medical or scientific name, if any, of the human cell base line that was used to develop or test the product. (b) Any person that fails to comply with the requirements of this section shall be subject to a fine in amount not to exceed $ or imprisonment for a period not to exceed , or both." SECTION 2. This Act does not affect rights and duties that matured, penalties that were incurred, and proceedings that were begun before its effective date. SECTION 3. New statutory material is underscored. SECTION 4. This Act shall take effect upon its approval. INTRODUCED BY: _____________________________
48	48
49	49	SECTION 1. Chapter 486, Hawaii Revised Statutes, is amended by adding a new section to part V to be appropriately designated and to read as follows:
50	50
51	51	"§486- Human cells; product labeling; requirements; penalties. (a) No person doing business in the State shall knowingly or intentionally expose any other person to a product developed or tested using human cells unless the product bears a warning label containing:
52	52
53	53	(1) A disclaimer that states that the product was developed or tested using one or more human cells; and
54	54
55	55	(2) The address of a website disclosing:
56	56
57	57	(A) The origin of each human cell that was used to develop or test the product was obtained;
58	58
59	59	(B) The method by which each human cell that was used to develop or test the product was obtained; and
60	60
61	61	(C) The medical or scientific name, if any, of the human cell base line that was used to develop or test the product.
62	62
63	63	(b) Any person that fails to comply with the requirements of this section shall be subject to a fine in amount not to exceed $ or imprisonment for a period not to exceed , or both."
64	64
65	65	SECTION 2. This Act does not affect rights and duties that matured, penalties that were incurred, and proceedings that were begun before its effective date.
66	66
67	67	SECTION 3. New statutory material is underscored.
68	68
69	69	SECTION 4. This Act shall take effect upon its approval.
70	70
71	71
72	72
73	73	INTRODUCED BY: _____________________________
74	74
75	75	INTRODUCED BY:
76	76
77	77	_____________________________
78	78
79	79
80	80
81	81
82	82
83	83	Report Title: Product Labeling; Human Cells; Penalties Description: Establishes labeling requirements for products that were developed or tested using human cells. The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.
84	84
85	85
86	86
87	87
88	88
89	89	Report Title:
90	90
91	91	Product Labeling; Human Cells; Penalties
92	92
93	93
94	94
95	95	Description:
96	96
97	97	Establishes labeling requirements for products that were developed or tested using human cells.
98	98
99	99
100	100
101	101
102	102
103	103
104	104
105	105	The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.